Clinical Case Database / Category: Case Based Discussion
Paraneoplastic syndromes
Publication details
Kiruthikah Thillai, Justin Waters
Foundation Years Journal, volume 6, issue 9, p.18 (123Doc Education, London, October 2012)
Abstract
Paraneoplastic syndromes encompass a heterogeneous group of rare disorders which exist as an indirect consequence of a primary tumour and its metastases. In some cases the syndrome may precede the diagnosis of cancer and an early and accurate recognition of the syndrome is therefore paramount. A case of the neurological paraneoplastic condition ‘Lambert Eaton Myasthenic Syndrome’ is presented here along with a discussion of the relevant investigations and subsequent management.
Access the Clinical Cases Database
A subscription is required to read the full article. Please subscribe using one of the options below.
Product | Price | Subscription | |
---|---|---|---|
Foundation Years Clinical Cases Database | £29.00 | 6 months | |
Foundation Years Clinical Cases Database | £39.00 | 12 months |
Authors
Kiruthikah Thillai
Specialist Registrar in Medical Oncology
Kent Oncology Centre,
Maidstone Hospital,
Hermitage Lane, Maidstone,
Kent, ME16 9QQ
Justin Waters
Consultant in Medical Oncology
Kent Oncology Centre,
Maidstone Hospital,
Hermitage Lane, Maidstone,
Kent, ME16 9QQ
References
1. Rinke A, Müller HH, Schade-Brittinger C, Klose KJ, Barth P, Wied M, Mayer C, Aminossadati B, Pape UF, Bläker M, Harder J, Arnold C, Gress T, Arnold R. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol, 27: 4656-4663 (2009)
2. O’Neill JH, Murray NM, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain : a journal of neurology, 111 ( Pt 3), 577-596 (1988).
3. Wirtz PW, Smallegange TM, Wintzen AR, Verschuuren JJ. Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases. Clinical neurology and neurosurgery, 104(4), 359-363 (2002).
4. Rosenfeld MR, Eichen JG, Wade DF, Posner JB, Dalmau J. Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Annals of neurology, 50(3), 339-348 (2001).
5. Dalmau J. Paraneoplastic disorders of the nervous system. Rinsho shinkeigaku = Clinical neurology, 48(11), 799-803 (2008).
6. Dalmau J, Gultekin HS, Posner JB. Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol, 9(2), 275-284 (1999).
7. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. The New England journal of medicine, 349(16), 1543-1554 (2003).
Disclaimers
Conflict Of Interest
The Journal requires that authors disclose any potential conflict of interest that they may have. This is clearly stated in the Journal’s published “Guidelines for Authors”. The Journal follows the Guidelines against Conflict of Interest published in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/urm_full.pdf).
Financial Statement
The authors of this article have not been paid. The Journal is financed by subscriptions and advertising. The Journal does not receive money from any other sources. The decision to accept or refuse this article for publication was free from financial considerations and was solely the responsibility of the Editorial Panel and Editor-in-Chief.
Patient Consent statement
All pictures and investigations shown in this article are shown with the patients’ consent. We require Authors to maintain patients’ anonymity and to obtain consent to report investigations and pictures involving human subjects when anonymity may be compromised. The Journal follows the Guidelines of the Uniform Requirements for Manuscripts (http://www.icmje.org/urm_full.pdf). The Journal requires in its Guidelines for Authors a statement from Authors that “the subject gave informed consent”.
Animal & Human Rights
When reporting experiments on human subjects, the Journal requires authors to indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the HelsinkiDeclaration of 1975, as revised in 2008.
About the Clinical Cases Database
The Foundation Years Clinical Cases Database is a selection of 600 peer-reviewed clinical cases in the field of patient safety and clinical practice, specifically focused on the clinical information needs of junior doctors, based around the Foundation Year Curriculum programme (MMC). The cases have been chosen to align with the Foundation Year Curriculum.
The database is fully searchable, or can be browsed by medical specialty. Abstracts can be read free of charge, however a subscription is required in order to read the complete cases.